Halozyme Therapeutics Inc. Common Stock vs Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) trades at $10.17 (market cap $112.95B). The key difference: Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) is far larger — about 9× Halozyme Therapeutics Inc. Common Stock's market cap, and Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) pays a 1.74% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares) for 1 Days on average.
| HALO | ITUB | |
|---|---|---|
Market Cap | $12.58B | $112.95B |
Volume | 2,179,278 | 44,012,203 |
Sector | Health | Financials |
52-Week High | $115.22 | $10.15 |
52-Week Low | $61.63 | $6.76 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $1.33T |
Dividend Yield | — | 1.74% |
Trailing returns across standard periods
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Itaú Unibanco is a Brazilian financial services company providing banking, credit, insurance, and investment products. It serves individual, business, and corporate clients.
Read more on ITUB →